UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000024180
Receipt number R000027137
Scientific Title Activated microglia and alpha 7 nicotinic acetylchorine receptors in schizophrenia: A PET study
Date of disclosure of the study information 2016/10/01
Last modified on 2024/04/05 09:38:57

No. Disposal Last modified on Item of update
1 Insert 2016/09/27 10:15:25
2 Update 2017/03/28 12:45:25


Key inclusion criteria
Key inclusion criteria
3 Update 2017/03/31 11:19:51 Organization1
Tel1
Email1
4 Update 2017/03/31 11:21:00 Recruitment status
5 Update 2017/09/28 14:56:03 Key secondary outcomes
Key secondary outcomes
6 Update 2017/09/28 14:59:26 Recruitment status
7 Update 2019/03/31 20:05:04 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
8 Update 2019/03/31 20:12:59 Target sample size
9 Update 2019/04/01 08:26:18 Institute
10 Update 2019/04/01 08:27:58 Date of IRB
Last follow-up date
11 Update 2020/03/31 00:31:47 Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
12 Update 2020/09/29 09:47:11 Target sample size
13 Update 2021/04/07 22:29:32 Public title
Public title
Scientific Title
Scientific Title
14 Update 2021/04/08 20:53:16 Co-sponsor
Co-sponsor
15 Update 2021/04/08 20:55:07 Co-sponsor
16 Update 2021/04/12 23:04:06 Co-sponsor
17 Update 2022/10/03 22:19:47 Last follow-up date
18 Update 2023/04/03 21:10:02 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
19 Update 2023/04/03 21:13:04 Number of participants that the trial has enrolled
20 Update 2024/04/04 08:01:27 Nationality of Funding Organization
21 Update 2024/04/05 09:38:57 URL releasing protocol
URL related to results and publications
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures